Gilead Sciences (GILD) Payout Ratio (2009 - 2026)

Gilead Sciences (GILD) has reported Payout Ratio for 13 consecutive years, with 0.1 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payout Ratio fell 119.32% year-over-year to 0.1; the trailing twelve-month figure through Jun 2026 stood at 1.4 (down 323.67% YoY), and the FY2025 full-year result was 0.47, down 94.25% from the prior year.
• Payout Ratio eased to 0.1 in Q2 2026 per GILD's latest filing, from 0.51 in the prior quarter.
• Across five years, Payout Ratio topped out at 78.75 in Q1 2022 and bottomed at 0.24 in Q1 2024.
• Historically, Payout Ratio has averaged 4.88 across 5 years, with a median of 0.56 in 2024.
• The sharpest annual moves came in 2022 and 2024: Payout Ratio jumped 14688.17% in 2022, then tumbled 124.1% in 2024.
• Over 5 years, Payout Ratio stood at 0.57 in 2022, then increased by 17.81% to 0.67 in 2023, then slipped by 18.44% to 0.55 in 2024, then slipped by 27.99% to 0.39 in 2025, then sank by 124.98% to 0.1 in 2026.
• According to Business Quant data, Payout Ratio over the past three periods registered 0.1, 0.51, and 0.39 for Q2 2026, Q1 2026, and Q4 2025 respectively.